CD3, CD4 & CD8 HIV Monitoring

Assay |
CD3, CD4 & CD8 HIV Monitoring |
Key Words |
CD348C, CD3, CD4, CD8, CD348, HIV |
Specimen Collection |
3.4ml EDTA (Red lid). For HIV monitoring only, not for diagnosis. Samples must not be refrigerated and must be <24 hours old due to white cell degradation. |
Turnaround time |
3 working days |
Test indications |
Monitoring CD4+ and CD8+ T lymphocyte count in patients with known HIV infection, to determine efficacy of antiretroviral medication. |
Interferences |
Haemolysis, clotted samples |
Reference Range |
See table below. Adult reference ranges from: Jentsch-Ullrich, K., et al. (2005). Lymphocyte subsets' reference ranges in an age- and gender-balanced population of 100 healthy adults—A monocentric German study. Clinical Immunology, 116(2), pp.192-197. Paediatric reference ranges from: Shearer, W., et al. (2003). Lymphocyte subsets in healthy children from birth through 18 years of age. Journal of Allergy and Clinical Immunology, 112(5), pp.973-980. |
Minimum retesting interval |
N/A |
Additional information |
Due to changes in procedure this test is currently not UKAS accredited. |
Age |
Cells per microlitre (% of cells) |
||
CD3+ |
CD3+ CD4+ |
CD3+ CD8+ |
|
0 – 3 months |
2500-5500 |
1600-4000 |
560-1700 |
(53-84) |
(35-64) |
(12-28) |
|
3 – 6 months |
2500-5600 |
1800-4000 |
590-1600 |
(51-77) |
(35-56) |
(12-23) |
|
6 – 12 months |
1900-5900 |
1400-4300 |
500-1700 |
(49-76) |
(31-56) |
(12-24) |
|
1 – 2 years |
2100-6200 |
1300-3400 |
620-2000 |
(53-75) |
(32-51) |
(14-30) |
|
2 – 6 years |
1400-3700 |
700-2200 |
490-1300 |
(56-75) |
(28-47) |
(16-30) |
|
6 – 12 years |
1200-2600 |
650-1500 |
370-1100 |
(60-76) |
(31-47) |
(18-35) |
|
12 – 18 years |
1000-2200 |
520-1300 |
330-920 |
(56-84) |
(31-52) |
(18-35) |
|
Male |
750-2240 |
450-1240 |
190-940 |
(52-77) |
(27-52) |
(11-40) |
|
Female |
750-2750 |
620-1990 |
210-820 |
(64-82) |
(33-56) |
(15-36) |
|
Male + female |
670-2180 |
480-1670 |
120-830 |
(54-88) |
(36-66) |
(9-41) |